- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07716436
Intradialytic Versus Home-Based Exercise in Female Hemodialysis Patients
Comparing the Effect of Intradialytic and Home-Based Exercise on Health Outcomes, Quality of Life, Self-Esteem, and Sexual Function in Female Hemodialysis Patients
This randomized controlled trial compared intradialytic exercise with home-based exercise in married female patients receiving maintenance hemodialysis. Ninety participants were randomly assigned in equal numbers to an intradialytic exercise group, a home-based exercise group, or a control group. Both exercise programs continued for 12 weeks.
The study evaluated whether exercise performed during dialysis or at home could improve quality of life, self-esteem, sexual function, and selected clinical and laboratory outcomes. Quality of life was assessed using the 36-Item Short Form Survey, self-esteem using the Rosenberg Self-Esteem Scale, and sexual function using the Female Sexual Function Index. Laboratory assessments included calcium, phosphorus, intact parathyroid hormone, albumin, C-reactive protein, hemoglobin, sodium, and potassium.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Gharbia Governorate
-
Tanta, Gharbia Governorate, Ägypten, 31511
- Tanta University Hospitals
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Female patients older than 18 years.
- Clinically stable.
- Receiving regular maintenance hemodialysis three times per week for at least three months.
- Able to perform mild- to moderate-intensity exercise.
Exclusion Criteria:
- Physical limitations preventing exercise.
- Acute illness.
- Unstable cardiovascular disease.
- Severe orthopedic or neurological disorders.
- Cognitive impairment affecting cooperation.
- Dialysis instability.
- Severe chronic kidney disease-mineral and bone disorder.
- Significant anemia.
- Retinal hemorrhage.
- History of hyperthyroidism.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Intradialytic Exercise
Participants performed low- to moderate-intensity aerobic and resistance exercises during the first two hours of hemodialysis, three times per week for 12 weeks.
Each session included a 5-minute warm-up, followed by aerobic and resistance exercises.
The conditioning phase started at 10 minutes and gradually increased to 30 minutes according to tolerance, followed by 5 minutes of relaxation and breathing exercises.
Exercise intensity was maintained at 60%-70% of maximal heart rate and monitored using the Borg scale.
Sessions were supervised by a trained dialysis nurse.
|
A supervised low- to moderate-intensity aerobic and resistance exercise program performed during the first two hours of hemodialysis, three times per week for 12 weeks.
|
|
Experimental: Home-Based Exercise
Participants performed a structured home-based exercise program for 30 minutes per day, at least three to five times per week, for 12 weeks.
The program included walking, bodyweight resistance exercises, and flexibility routines.
Participants received instructions on safe exercise performance and were advised to adjust the exercise intensity according to tolerance.
|
A structured home-based exercise program consisting of walking, bodyweight resistance exercises, and flexibility routines for 30 minutes per day, at least three to five times per week for 12 weeks.
|
|
Kein Eingriff: Control
Participants continued their usual hemodialysis care without a structured exercise program during the 12-week study period.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Health-Related Quality of Life
Zeitfenster: Baseline and 12 weeks
|
Change in Health-Related Quality of Life was assessed by the 36-Item Short Form Survey.
The 36-Item Short Form Survey consists of 36 items covering eight health domains: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, energy/fatigue, social functioning, role limitations due to emotional problems, and emotional well-being.
Each domain is scored from 0 to 100, with 0 representing the lowest possible health status and 100 representing the highest possible health status.
Higher scores indicate better health-related quality of life.
The validated Arabic version was used.
|
Baseline and 12 weeks
|
|
Self-Esteem
Zeitfenster: Baseline and 12 weeks
|
Change in Self-Esteem was assessed by the Rosenberg Self-Esteem Scale.
The Rosenberg Self-Esteem Scale consists of 10 items assessing global self-esteem, including five positively worded and five negatively worded statements.
Higher total scores indicate higher self-esteem.
|
Baseline and 12 weeks
|
|
Female sexual function
Zeitfenster: Baseline and 12 weeks
|
Change in Female Sexual Function was assessed by the Female Sexual Function Index.
The Female Sexual Function Index consists of 19 items covering six domains of female sexual function: desire, arousal, lubrication, orgasm, satisfaction, and pain.
The total score ranges from 2 to 36, with higher scores indicating better sexual function.
The validated Arabic version was used.
|
Baseline and 12 weeks
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Urogenitale Erkrankungen
- Pathologische Prozesse
- Männliche Urogenitalerkrankungen
- Nierenerkrankungen
- Urologische Erkrankungen
- Weibliche Urogenitalerkrankungen
- Weibliche Urogenitalerkrankungen und Schwangerschaftskomplikationen
- Chronische Erkrankung
- Krankheitsattribute
- Niereninsuffizienz
- Niereninsuffizienz, chronisch
- Pathologische Zustände, Anzeichen und Symptome
- Verhalten
- Nierenversagen, chronisch
- Motorik
Andere Studien-ID-Nummern
- 36264PR1100/2/25
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
IPD-Sharing-Zeitrahmen
IPD-Sharing-Zugriffskriterien
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- SAFT
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .